About us

The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products.

Who we are

The Commission on Human Medicines was established in October 2005. Its functions are set out in regulation 10 of the Human Medicines Regulations 2012 (SI 2012/1916).

Our responsibilities

We’re responsible for:

  • advising on applications for both national and European marketing authorisations
  • considering further representation against our provisional advice in respect of national applications
  • advising on the need for, and content of, risk management plans for new medicines
  • advising on the impact of new safety issues on the balance of risks and benefits of licensed medicines - eg adding warnings, restricting or suspending use of a medicine
  • advising the licensing authority on changes to legal status of marketing authorisations